BIOGEN INC. Investing Cash Flow
BIOGEN INC. (BIIB) reported Investing Cash Flow of -$209.50 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-04-29
- BIOGEN INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$209.50M.
- BIOGEN INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$1.23B.
- BIOGEN INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$35.10M.
- BIOGEN INC. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was -$57.00M, a 112.22% decline year-over-year.
- BIOGEN INC. net cash provided by (used in) investing activities for fiscal 2025 was -$1.37B.
- BIOGEN INC. net cash provided by (used in) investing activities for fiscal 2024 was -$799.20M.
- BIOGEN INC. net cash provided by (used in) investing activities for fiscal 2023 was -$4.10B, a 360.12% decline from fiscal 2022.
- BIOGEN INC. net cash provided by (used in) investing activities for fiscal 2022 was $1.58B.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$209.50M 10-Q · filed 2026-04-29 | -$1.44B derived: sum of 2 quarters · filed 2026-04-29 | -$1.48B derived: sum of 3 quarters · filed 2026-04-29 | -$1.53B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$1.23B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$1.27B derived: sum of 2 quarters · filed 2026-02-06 | -$1.32B derived: sum of 3 quarters · filed 2026-02-06 | -$1.37B 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | -$35.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$92.10M derived: sum of 2 quarters · filed 2025-10-30 | -$139.40M 10-Q · filed 2025-10-30 | -$158.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | -$57.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$104.30M 10-Q · filed 2025-07-31 | -$122.90M derived: sum of 3 quarters · filed 2026-04-29 | -$1.30B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | -$47.30M 10-Q · filed 2026-04-29 | -$65.90M derived: sum of 2 quarters · filed 2026-04-29 | -$1.25B derived: sum of 3 quarters · filed 2026-04-29 | -$780.50M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | -$18.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$1.20B derived: sum of 2 quarters · filed 2026-02-06 | -$733.20M derived: sum of 3 quarters · filed 2026-02-06 | -$799.20M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | -$1.18B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$714.60M derived: sum of 2 quarters · filed 2025-10-30 | -$780.60M 10-Q · filed 2025-10-30 | -$1.43B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $466.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $400.50M 10-Q · filed 2025-07-31 | -$251.80M derived: sum of 3 quarters · filed 2026-02-06 | -$1.99B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | -$66.00M 10-Q · filed 2025-05-01 | -$718.30M derived: sum of 2 quarters · filed 2026-02-06 | -$2.46B derived: sum of 3 quarters · filed 2026-02-06 | -$3.21B derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | -$652.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$2.39B derived: sum of 2 quarters · filed 2026-02-06 | -$3.15B derived: sum of 3 quarters · filed 2026-02-06 | -$4.10B 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | -$1.74B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$2.50B derived: sum of 2 quarters · filed 2024-10-30 | -$3.45B 10-Q · filed 2024-10-30 | -$3.59B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$753.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$1.71B 10-Q · filed 2024-08-01 | -$1.85B derived: sum of 3 quarters · filed 2025-02-12 | -$175.40M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | -$953.00M 10-Q · filed 2024-04-24 | -$1.09B derived: sum of 2 quarters · filed 2025-02-12 | $578.10M derived: sum of 3 quarters · filed 2025-02-12 | $1.27B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$141.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $1.53B derived: sum of 2 quarters · filed 2025-02-12 | $2.22B derived: sum of 3 quarters · filed 2025-02-12 | $1.58B 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $1.67B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $2.37B derived: sum of 2 quarters · filed 2023-11-08 | $1.72B 10-Q · filed 2023-11-08 | $1.60B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $693.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $45.50M 10-Q · filed 2023-07-25 | -$67.20M derived: sum of 3 quarters · filed 2024-02-14 | -$300.80M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$648.00M 10-Q · filed 2023-04-25 | -$760.70M derived: sum of 2 quarters · filed 2024-02-14 | -$994.30M derived: sum of 3 quarters · filed 2024-02-14 | -$1.15B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | -$112.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$346.30M derived: sum of 2 quarters · filed 2024-02-14 | -$499.00M derived: sum of 3 quarters · filed 2024-02-14 | -$563.70M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | -$233.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$386.30M derived: sum of 2 quarters · filed 2022-10-25 | -$451.00M 10-Q · filed 2022-10-25 | -$617.40M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | -$152.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | -$217.40M 10-Q · filed 2022-07-20 | -$383.80M derived: sum of 3 quarters · filed 2023-02-15 | -$436.20M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | -$64.70M 10-Q · filed 2022-05-03 | -$231.10M derived: sum of 2 quarters · filed 2023-02-15 | -$283.50M derived: sum of 3 quarters · filed 2023-02-15 | -$1.12B derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$166.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$218.80M derived: sum of 2 quarters · filed 2023-02-15 | -$1.05B derived: sum of 3 quarters · filed 2023-02-15 | -$608.60M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | -$52.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$885.10M derived: sum of 2 quarters · filed 2021-10-20 | -$442.20M 10-Q · filed 2021-10-20 | $266.20M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | -$832.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | -$389.80M 10-Q · filed 2021-07-22 | $318.60M derived: sum of 3 quarters · filed 2022-02-03 | -$47.30M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $442.90M 10-Q · filed 2021-04-22 | $1.15B derived: sum of 2 quarters · filed 2022-02-03 | $785.40M derived: sum of 3 quarters · filed 2022-02-03 | $674.60M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $708.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $342.50M derived: sum of 2 quarters · filed 2022-02-03 | $231.70M derived: sum of 3 quarters · filed 2022-02-03 | $470.50M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | -$365.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | -$476.70M derived: sum of 2 quarters · filed 2020-10-21 | -$237.90M 10-Q · filed 2020-10-21 | -$1.86B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | -$110.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $128.00M 10-Q · filed 2020-07-22 | -$1.50B derived: sum of 3 quarters · filed 2021-02-03 | -$2.12B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $238.80M 10-Q · filed 2020-04-23 | -$1.39B derived: sum of 2 quarters · filed 2021-02-03 | -$2.01B derived: sum of 3 quarters · filed 2021-02-03 | -$3.15B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | -$1.63B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | -$2.24B derived: sum of 2 quarters · filed 2021-02-03 | -$3.39B derived: sum of 3 quarters · filed 2021-02-03 | -$2.05B 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | -$619.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | -$1.77B derived: sum of 2 quarters · filed 2019-10-22 | -$421.00M 10-Q · filed 2019-10-22 | -$1.19B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | -$1.15B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $198.10M 10-Q · filed 2019-07-24 | -$571.40M derived: sum of 3 quarters · filed 2020-02-06 | -$1.82B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $1.35B 10-Q · filed 2019-04-24 | $577.10M derived: sum of 2 quarters · filed 2020-02-06 | -$669.80M derived: sum of 3 quarters · filed 2020-02-06 | -$872.30M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | -$769.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | -$2.02B derived: sum of 2 quarters · filed 2020-02-06 | -$2.22B derived: sum of 3 quarters · filed 2020-02-06 | -$2.96B 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | -$1.25B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$1.45B derived: sum of 2 quarters · filed 2018-10-23 | -$2.19B 10-Q · filed 2018-10-23 | -$2.78B derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | -$202.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | -$946.70M 10-Q · filed 2018-07-24 | -$946.80M 10-Q · filed 2017-07-25 | -$1.53B derived: sum of 3 quarters · filed 2019-02-06 | -$1.49B derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2017-03-31 | -$744.20M 10-Q · filed 2018-04-24 | -$1.33B derived: sum of 2 quarters · filed 2019-02-06 | -$1.29B derived: sum of 3 quarters · filed 2019-02-06 | -$2.03B derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | -$581.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$545.50M derived: sum of 2 quarters · filed 2019-02-06 | -$1.28B derived: sum of 3 quarters · filed 2019-02-06 | -$2.48B 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | $36.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$699.90M derived: sum of 2 quarters · filed 2017-10-24 | -$1.90B 10-Q · filed 2017-10-24 | -$3.71B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | -$736.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | -$1.94B 10-Q · filed 2017-07-25 | -$3.75B derived: sum of 3 quarters · filed 2018-02-01 | -$4.74B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | -$1.20B 10-Q · filed 2017-04-25 | -$3.01B derived: sum of 2 quarters · filed 2018-02-01 | -$4.00B derived: sum of 3 quarters · filed 2018-02-01 | -$5.25B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | -$1.81B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$2.80B derived: sum of 2 quarters · filed 2018-02-01 | -$4.05B derived: sum of 3 quarters · filed 2018-02-01 | -$4.55B 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | -$990.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | -$2.24B derived: sum of 2 quarters · filed 2016-10-26 | -$2.75B 10-Q · filed 2016-10-26 | -$2.75B 10-Q · filed 2015-10-21 | -$3.12B derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | -$1.25B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | -$1.76B 10-Q · filed 2016-07-21 | -$1.76B 10-Q · filed 2015-07-24 | -$2.13B derived: sum of 3 quarters · filed 2017-02-02 | -$2.67B derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | -$502.80M 10-Q · filed 2016-04-21 | -$502.77M 10-Q · filed 2015-04-24 | -$881.10M derived: sum of 2 quarters · filed 2017-02-02 | -$1.42B derived: sum of 3 quarters · filed 2017-02-02 | -$2.05B derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | -$378.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$918.87M derived: sum of 2 quarters · filed 2017-02-02 | -$1.55B derived: sum of 3 quarters · filed 2017-02-02 | -$1.54B 10-K · filed 2017-02-02 | -$1.54B 10-K · filed 2015-02-04 | |||
| 2014-09-30 | -$540.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | -$1.17B derived: sum of 2 quarters · filed 2015-10-21 | -$1.16B 10-Q · filed 2015-10-21 | -$1.87B derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | -$630.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | -$624.13M 10-Q · filed 2015-07-24 | -$1.33B derived: sum of 3 quarters · filed 2016-02-03 | -$1.66B derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $5.99M 10-Q · filed 2015-04-24 | -$704.01M derived: sum of 2 quarters · filed 2016-02-03 | -$1.03B derived: sum of 3 quarters · filed 2016-02-03 | -$1.75B derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | -$710.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$1.03B derived: sum of 2 quarters · filed 2016-02-03 | -$1.76B derived: sum of 3 quarters · filed 2016-02-03 | -$1.60B 10-K · filed 2016-02-03 | -$1.60B 10-K · filed 2014-02-06 | |||
| 2013-09-30 | -$324.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | -$1.05B derived: sum of 2 quarters · filed 2014-10-22 | -$894.69M 10-Q · filed 2014-10-22 | -$1.27B derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | -$726.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | -$570.30M 10-Q · filed 2014-07-23 | -$945.75M derived: sum of 3 quarters · filed 2015-02-04 | -$1.47B derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $155.94M 10-Q · filed 2014-04-23 | -$219.51M derived: sum of 2 quarters · filed 2015-02-04 | -$741.90M derived: sum of 3 quarters · filed 2015-02-04 | -$795.02M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | -$375.45M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | -$897.84M derived: sum of 2 quarters · filed 2015-02-04 | -$950.96M derived: sum of 3 quarters · filed 2015-02-04 | -$950.34M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | -$522.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$575.51M derived: sum of 2 quarters · filed 2013-10-28 | -$574.89M 10-Q · filed 2013-10-28 | -$964.42M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | -$53.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$52.50M 10-Q · filed 2013-07-25 | -$442.03M derived: sum of 3 quarters · filed 2014-02-06 | -$1.03B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $618.00K 10-Q · filed 2013-04-25 | -$388.91M derived: sum of 2 quarters · filed 2014-02-06 | -$976.09M derived: sum of 3 quarters · filed 2014-02-06 | -$1.52B derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | -$389.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$976.71M derived: sum of 2 quarters · filed 2014-02-06 | -$1.52B derived: sum of 3 quarters · filed 2014-02-06 | -$1.65B 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | -$587.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | -$1.13B derived: sum of 2 quarters · filed 2012-10-25 | -$1.26B 10-Q · filed 2012-10-25 | -$1.78B derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | -$546.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | -$673.59M 10-Q · filed 2012-07-24 | -$1.19B derived: sum of 3 quarters · filed 2013-02-05 | -$1.26B derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | -$126.80M 10-Q · filed 2012-05-01 | -$645.42M derived: sum of 2 quarters · filed 2013-02-05 | -$715.17M derived: sum of 3 quarters · filed 2013-02-05 | -$31.21M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | -$518.62M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | -$588.38M derived: sum of 2 quarters · filed 2013-02-05 | $95.59M derived: sum of 3 quarters · filed 2013-02-05 | $345.32M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | -$69.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $614.21M derived: sum of 2 quarters · filed 2011-10-28 | $863.95M 10-Q · filed 2011-10-28 | $1.25B derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | $683.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | $933.70M 10-Q · filed 2011-07-26 | $1.32B derived: sum of 3 quarters · filed 2012-02-03 | $841.89M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | $249.74M 10-Q · filed 2011-04-21 | $632.36M derived: sum of 2 quarters · filed 2012-02-03 | $157.93M derived: sum of 3 quarters · filed 2012-02-03 | -$53.59M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | $382.62M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | -$91.81M derived: sum of 2 quarters · filed 2012-02-03 | -$303.32M derived: sum of 3 quarters · filed 2012-02-03 | -$395.03M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | -$474.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | -$685.95M derived: sum of 2 quarters · filed 2010-10-26 | -$777.65M 10-Q · filed 2010-10-26 | -$1.24B derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-06-30 | -$211.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-20 | -$303.22M 10-Q · filed 2010-07-20 | -$768.98M derived: sum of 3 quarters · filed 2011-02-04 | -$868.45M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | -$91.71M 10-Q · filed 2010-04-20 | -$557.46M derived: sum of 2 quarters · filed 2011-02-04 | -$656.93M derived: sum of 3 quarters · filed 2011-02-04 | |||||
| 2008-12-31 | -$465.76M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | -$565.23M derived: sum of 2 quarters · filed 2011-02-04 | -$365.87M 10-K · filed 2011-02-04 | |||||
| 2008-09-30 | -$99.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | $99.88M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | $199.35M 10-Q · filed 2009-07-17 | |||||||
| 2007-12-31 | -$286.57M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |